ChoA Pharmaceutical Co.Ltd (034940) — Cash Flow Quality Index
ChoA Pharmaceutical Co.Ltd (034940) has a Cash Flow Quality Index of -92.13x as of March 2026. Operating cash flow of ₩-2.41 Billion is below net income of ₩26.14 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ChoA Pharmaceutical Co.Ltd (034940) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ChoA Pharmaceutical Co.Ltd Cash Flow Quality Index (2004–2022)
Historical Cash Flow Quality Index for ChoA Pharmaceutical Co.Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 034940 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ChoA Pharmaceutical Co.Ltd (2004–2022)
Year-by-year earnings quality comparison for ChoA Pharmaceutical Co.Ltd. For live market cap and the full company financial profile, see market cap of ChoA Pharmaceutical Co.Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -2.57x | ₩-1.44 Billion | ₩560.69 Million | ▼ -180.7% |
| 2018 | 3.19x | ₩2.04 Billion | ₩641.14 Million | ▲ +866.5% |
| 2017 | -0.42x | ₩-675.51 Million | ₩1.62 Billion | ▼ -105.1% |
| 2016 | 8.18x | ₩930.42 Million | ₩113.74 Million | ▲ +549.9% |
| 2015 | 1.26x | ₩1.19 Billion | ₩943.10 Million | ▼ -35.7% |
| 2013 | 1.96x | ₩3.53 Billion | ₩1.80 Billion | ▼ -16.2% |
| 2004 | 2.34x | ₩3.57 Billion | ₩1.53 Billion | — |